Haloperidol Injection, Solution
Product Images NDC 51662-1524

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Haloperidol (NDC 51662-1524). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Adverse Reactions (Adverse Reactions)

Table showing adverse reactions occurring in 1% or more of patients treated with Haloperidol compared to placebo in double-blind, placebo-controlled clinical trials of oral Haloperidol. Reactions are categorized by system/organ class, including gastrointestinal and nervous system disorders, with percentages listed for both Haloperidol and placebo groups.*

FDA Label Image

Boxed Warning (Boxed Warning)

A warning text panel from the Haloperidol injection label. It discusses increased mortality risk in elderly patients with dementia-related psychosis treated with antipsychotic drugs, citing study data and causes of death. It notes Haloperidol Injection USP is not approved for this use and refers to additional warnings.*

FDA Label Image

How Supplied (How Supplied)

A data table presenting different product codes, units of sale, strengths, and packaging details for haloperidol lactate injection solutions. It shows a 5 mg/mL strength in a 2 mL vial sold in units of 25, and a 50 mg per 10 mL strength (5 mg per mL) in a 10 mL multiple dose vial, including corresponding NDC codes for each configuration.*

FDA Label Image

Logo (Spl Logo)

FDA Label Image

Serialized Labeling (Serialized Vial Labeling 51662 1524 1)

Haloperidol 5 mg/mL injection solution in a 1 mL single dose vial for intramuscular use. The vial has a yellow cap and a label indicating it is for immediate release. The label and adjacent barcode panel show distribution by HF Acquisition Co LLC, Mukilteo, WA.*

FDA Label Image

Structure (Structure)

Chemical structure of Haloperidol Lactate (C21H23ClFNO2) with a molecular weight of 375.86, depicted as connected rings and atoms in a 2D molecular diagram.*

FDA Label Image

Vil Label (Vial Label 51662 1524 1)

Label of Haloperidol Injection USP, 5 mg per mL, an intramuscular injection solution. The label states it is for immediate release, sterile, and should be protected from light. It indicates a 1 mL single dose vial and is marked Rx only. The label includes the manufacturer Fresenius Kabi.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.